After-Hours Movers 06/14: (CIDM) (CPST) Higher; (DYAX) Lower

June 14, 2012 5:49 PM EDT Send to a Friend
Get Alerts DYAX Hot Sheet
Trade DYAX Now!
Join SI Premium – FREE
Dyax Corp. (Nasdaq: DYAX) 13.7% LOWER; reports the decision to discontinue the Companys Phase 2 trial investigating ecallantide in the acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema based upon the results of an interim analysis. This double-blind, placebo-controlled, randomized, dose-ranging study was designed to evaluate the efficacy and safety of ecallantide (10, 30, or 60 mg subcutaneous doses) compared to placebo, with a goal of enrolling 176 patients. The primary endpoint was the proportion of patients meeting a set of criteria indicating eligibility for discharge from the emergency department within 6 hours following study drug administration. Click here to see the full report.

Cinedigm Digital Cinema (NASDAQ: CIDM) 4% HIGHER; reported Q4 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $17.7 million versus the consensus estimate of $18.73 million.

Capstone Turbine Corp (NASDAQ: CPST) 2% HIGHER; reported Q4 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $30.1 million versus the consensus estimate of $29.93 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

After-Hours Movers

Add Your Comment